Ryan Pappas
Clinical Neurophysiology · Valparaiso, INNPI 1235577065
Payments from drug & device makers
Across 169 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$620
- AbbVie$515
- Sunovion Pharmaceuticals Inc.$275
- Supernus Pharmaceuticals, Inc.$138
- Teva Pharmaceuticals USA, Inc.$118
- Lundbeck LLC$100
- plus $1K from 33 others
What the payments were for
- Travel & lodging$60719%
- Food & beverage$2,53881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $620 |
| AbbVie(2 entities) | 37 | $515 |
| Sunovion Pharmaceuticals Inc. | 35 | $275 |
| Supernus Pharmaceuticals, Inc. | 9 | $138 |
| Teva Pharmaceuticals USA, Inc. | 7 | $118 |
| Lundbeck LLC | 5 | $100 |
| W. L. Gore & Associates, Inc. | 1 | $85 |
| Biogen | 4 | $75 |
| UCB, Inc. | 5 | $75 |
| Amneal Pharmaceuticals LLC | 4 | $72 |
| Adamas Pharmaceuticals, Inc. | 4 | $67 |
| Amgen | 2 | $63 |
| Sanofi | 4 | $62 |
| Lilly USA, LLC | 4 | $61 |
| Novartis | 4 | $58 |
| Avanir Pharmaceuticals, Inc. | 3 | $51 |
| Abbott | 1 | $50 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Johnson & Johnson | 2 | $45 |
| Merz North America, Inc. | 2 | $44 |
| Upsher-smith Laboratories LLC | 3 | $42 |
| Harmony Biosciences LLC | 1 | $42 |
| Assertio Therapeutics, Inc. | 3 | $39 |
| Eisai Inc. | 1 | $37 |
| Livanova USA, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $34 |
| Zyla Life Sciences, Inc. | 3 | $34 |
| Neurelis, Inc. | 2 | $31 |
| SK Life Science, Inc. | 2 | $29 |
| Catalyst Pharmaceuticals, Inc. | 1 | $27 |
| EMD Serono, Inc. | 2 | $24 |
| CSL Behring | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| MDD US Operations, LLC | 1 | $13 |
| OWP Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA$607
How this compares
Too few clinical neurophysiology providers in Indianato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbamazepine | 26 | $817 |
Paid to pharmacies, not to this prescriber.
Other clinical neurophysiology in Valparaiso
- Mohammed HasnainJeffersonville$7K
- Nadia BowlingGranger$4K
- Kiesha AndersonGranger$1K
- Jitendra SharmaKokomo$157
- Trevor LoganIndianapolis$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.